Table 2.
Summary of net population and per case clinical outcomes of HD-QIV versus aQIV (base-case results): hospitalizations possibly related to influenza.
| Clinical outcomes | aQIV strategy | HD-QIV strategy | Differential | ICER |
|---|---|---|---|---|
| Net population clinical outcomes | ||||
| Cases of influenza | 736,036 | 666,048 | −69,987 | |
| Influenza-related medical visits | 284,110 | 257,095 | −27,015 | |
| Influenza-related emergency room visits | 6,022 | 5,420 | −602 | |
| Hospitalizations – cardio-respiratory events | 474,864 | 431,094 | −43,771 | |
| Deaths | 6,129 | 4,309 | −1,820 | |
| QALYs | 121,296,794 | 121,313,772 | 16,978 | |
| LYs | 139,782,102 | 139,800,015 | 17,913 | |
| Per case clinical outcomes | ||||
| Total costs | 153.82 € | 149.9 € | −3.92 € | – |
| Total LYs | 10.2447 | 10.246 | 0.0013 | Dominant |
| Total QALYs | 8.8899 | 8.8912 | 0.0012 | Dominant |